Genelux Corporation to Participate in a Fireside Chat at H.C. Wainwright Global Investment Conference Sep 2, 2025 04:01PM
Genelux Corporation Reports Second Quarter 2025 Financial Results and Provides General Business Updates Aug 7, 2025 04:20PM
Genelux Corporation Announces Appointment of Eric Groen as General Counsel, Corporate Secretary, Chief Compliance Officer and Head of Business Development Jul 7, 2025 07:00AM
Genelux Corporation Reports First Quarter 2025 Financial Results and Provides General Business Updates May 6, 2025 04:10PM
Genelux Corporation to Participate in a Fireside Chat at the Citizens Life Sciences Conference May 1, 2025 04:05PM


Mar 28, 2025 04:10PM Genelux Corporation Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update
Mar 25, 2025 08:33AM Genelux (GNLX) and Newsoara Announce Positive Preliminary Phase 1b/2 Data of Olvi-Vec in Advanced Small-Cell Lung Cancer
Mar 25, 2025 08:30AM Genelux and Newsoara Announce Positive Preliminary Phase 1b/2 Data of Olvi-Vec in Advanced Small-Cell Lung Cancer
Feb 3, 2025 06:46AM Genelux (GNLX) Appoints Matthew Pulisic as CFO
Feb 3, 2025 06:45AM Genelux Corporation Announces New Chief Financial Officer
Dec 13, 2024 07:01AM Genelux Corporation to Participate in a Fireside Chat with H.C. Wainwright
Nov 14, 2024 04:05PM Genelux Corporation Reports Third Quarter 2024 Financial Results and Provides General Business Updates
Nov 6, 2024 04:01PM Genelux Corporation to Participate in Fireside Chat at the Guggenheim Inaugural Healthcare Innovation Conference
Oct 22, 2024 04:04PM Genelux (GNLX) Announces First Patient Dosed in Phase 2 Trial Evaluating Systemic Therapy with Olvi-Vec in Non-Small Cell Lung Cancer
Oct 22, 2024 04:01PM Genelux Corporation Announces First Patient Dosed in Phase 2 Trial Evaluating Systemic Therapy with Olvi-Vec in Non-Small Cell Lung Cancer
Oct 9, 2024 04:15PM Genelux Corporation to Participate in the 2024 Maxim Healthcare Virtual Summit
Sep 3, 2024 04:01PM Genelux Corporation to Present at the H.C. Wainwright Global Investment Conference
Aug 14, 2024 04:05PM Genelux Corporation Reports Second Quarter 2024 Financial Results and Provides General Business Updates
Jul 30, 2024 07:00AM Genelux Corporation to Participate in Fireside Chat at BTIG’s Virtual Biotechnology Conference 2024
May 9, 2024 04:25PM Genelux Corporation Reports First Quarter 2024 Financial Results and Provides General Business Updates
Apr 1, 2024 07:00AM Genelux Corporation Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
Nov 27, 2023 07:03AM Genelux (GNLX) Receives FDA Fast Track Designation for Olvi-Vec in Platinum Resistant/Refractory Ovarian Cancer
Nov 27, 2023 07:00AM Genelux Corporation Receives FDA Fast Track Designation for Olvi-Vec in Platinum Resistant/Refractory Ovarian Cancer
Nov 14, 2023 05:50PM Genelux Corporation Reports Third Quarter 2023 Financial Results and Provides General Business Updates
Sep 14, 2023 07:00AM Genelux Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Sep 7, 2023 04:01PM Genelux Corporation to Present at the H.C. Wainwright Global Investment Conference
Aug 28, 2023 07:00AM Genelux Corporation Announces New Chief Financial Officer
Aug 14, 2023 07:00AM Genelux Corporation Reports Second Quarter 2023 Financial Results and Provides General Business Updates
Aug 2, 2023 04:00PM Genelux Corporation to Participate in Fireside Chat at BTIG’s Virtual Biotechnology Conference 2023
Jul 20, 2023 04:45PM Genelux (GNLX) Announces Management Changes
Jul 20, 2023 04:45PM Genelux Corporation Strengthens Senior Management and Clinical Team with Promotions and New Hires
Jun 22, 2023 07:01AM Genelux (GNLX) to Join the Russell 3000 and Russell 2000 Indexes
Jun 22, 2023 07:00AM Genelux Corporation Set to Join the Russell 3000® and Russell 2000® Indexes Effective June 26, 2023
Mar 23, 2023 07:00AM Genelux Corporation to Ring Nasdaq Opening Bell on March 29, 2023
Mar 23, 2023 07:00AM Genelux Corporation to Ring Nasdaq Opening Bell on March 29, 2023